PHILADELPHIA, July 28, 2014 /PRNewswire/ — The Intellectual Property and Science Business of Thomson Reuters, the world’s leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatitis Day on Life Sciences Connect, a blog exploring the latest news and trends in Life Sciences and updates on the drug pipeline identifying multiple treatments in development that may serve as potential alternatives to Gilead’s Sovaldi, currently priced in the United States at $84,000 for 12 weeks of treatment — $1,000 per pill.
Hepatitis is an inflammation of the liver and there are five main hepatitis viruses, referred to as types A, B, C, D and E — plus types X and G. The five main types are of the greatest concern because of the burden of illness and death they cause and the potential for epidemic outbreaks. In particular, types B and C lead to chronic disease in hundreds of millions of people and, together, are the most common cause of liver cirrhosis and cancer, killing close to 1.4 million every year according to the World Health Organization (WHO).
In late 2013, Gilead dramatically changed the hepatitis C treatment landscape with the launch of Sovaldi, an effective cure for many when used in combination with ribavirin. However, the high cost of the treatment keeps it out of reach for the majority of the estimated 130-150 million individuals suffering from the disease.
To raise additional awareness for World Hepatitis Day, Life Sciences Connect analysts complied Sovaldi-Innovative, Cost Effective, Unaffordable, utilizing Cortellis™Competitive Intelligence, the pharmaceutical industry’s leading source for drug pipeline, deals, patents, and company content, to evaluate the current outlook of therapies in the pipeline. The analysis revealed several alternative treatments in various stages of development. This high activity is expected to create competition that will lessen costs of treatment, making it more affordable and accessible to patients.
The following were among the key treatments found in different stages of development:
Drug & Mechanism of Action
Indications Under Development
a nucleoside analog NS5B
Phase II for Hepatitis
orally available combination
Potential launch in 2015
veruprevir (HCV NS3/4A protease
Expected launch Q1 2015
The analysis also includes an infographic illustrating significant shifts in the Hepatitis drug market.
“We conducted this study in recognition of World Hepatitis Day to help raise awareness around this potentially devastating disease and spotlight some drugs in development that may help eradicate it,” said Jon Brett-Harris, managing director of Thomson Reuters IP & Science. “One of the largest barriers in treating hepatitis is accessibility, therefore it is critical to identify the key drugs in development that may help make treatment more attainable.”
Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions
HONG KONG, July 28, 2014 /PRNewswire/ — Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that its new PicoWay® device has received CE Mark indication to treat tattoos of all types and colors and pigmented lesions on any skin type. PicoWay is a new and innovative dual wavelength device, with 532nm and 1064nm wavelengths, which utilizes Syneron’s proprietary PicoWay technology to deliver energy to the skin using pulses which are trillionths of a second, known as picosecond pulses. Syneron will begin a staged launch of the PicoWay device in the international market during the third quarter of 2014 and anticipates that it will receive U.S. Food and Drug Administration (FDA) clearance for PicoWay by the end of 2014.
PicoWay’s high peak power and ultra-short pulse duration enable a unique mode of action which creates the strongest photo-mechanical impact to break up the tattoo ink or the pigmentation. This revolutionary PicoWay technology is integrated into a proven, reliable Candela® platform which ensures superior performance and low cost of ownership.
“Our investment in PicoWay’s research and development demonstrate Syneron’s commitment to develop technology that enables physicians to provide best-in-practice treatments for their patients,” stated Amit Meridor, CEO of Syneron. “Since PicoWay has the shortest picosecond pulse duration and the highest peak power of any device on the market, we believe that fewer treatments will be needed and that the percentage clearance will be higher. We are pleased that Dr. Chan will present his positive results with PicoWay at IMCAS Asia, particularly because it will be a significant market for PicoWay due to the special value placed on clear skin in Asia.”
Dr. Henry Chan, specialist in dermatology in Hong Kong, will present the interim results of a multi-center study focused on treating pigmented lesions with PicoWay at the IMCAS Asia Conference slated for August 1-3, 2014 in Hong Kong. His presentation is entitled “The Use of Picosecond Lasers on Asians”.
Dr. Chan says “PicoWay’s unique mode of picosecond action enables full flexibility to adjust the wavelength, fluence, spot size and rep rate, providing customizable treatments which ensure outstanding clinical results. The novel PicoWay technology enables our clinic to offer a new and exciting solution to remove pigmented lesions. The treatments have proven to be effective, safe and comfortable with a high satisfaction rate among our patients.”
Syneron Medical Ltd. is a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company’s technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, improving the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under three distinct brands, Syneron, Candela and CoolTouch.
Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the U.S. The company markets, services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.
For additional information, please visit http://www.syneron-candela.com.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, treatment results, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings and market shares. The statements made by the Company are based upon management’s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions, market acceptance of new products, and other factors beyond the Company’s control and the risk factors and other cautionary statements described in the Company’s filings with the SEC, including those described in the Company’s most recent Annual Report on Form 20-F, and the other factors described in the filings that Syneron Medical makes with the SEC. If one or more of these factors materialize, or if any underlying assumptions prove incorrect, Syneron Medical Ltd.’s actual results, performance or achievements may vary materially from any future results, performance or achievements expressed or implied by these forward-looking statements. These forward-looking statements should not be relied upon as representing Syneron Medical Ltd.’s views as of any date after the date of this document. The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.
Additional information can be found at www.syneron-candela.com
BEIJING, July 28, 2014 /PRNewswire/ — Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnos…
SANTA CLARA, Calif., July 28, 2014 /PRNewswire/ — ProteinSimple announced today that it has launched a total protein assay for the Simple Western. This new assay allows users to detect all proteins separated in the assay simultaneously. For the first time, Simple Western users can analyze proteins without the need for an antibody.
The Simple Western has changed protein analysis as we know it today. First, the Simple Western eliminated the hassles of Western blot protocols – no messy gels, no transfer tanks, no blots, no imaging and no manual analysis. Simply load your samples, push a button, walk away and come back to fully analyzed, highly consistent data.
Now, with the Total Protein Master Kit, the benefits of the Simple Western are available to researchers who are currently forced to run a gel and deal with tedious staining protocols just to visualize and quantitate an overexpressed protein or evaluate the amount of a protein in a complex cell lysate. When using the Simple Western platform, these researchers will never have to run a gel again or do that manual analysis.
The Simple Western platform consists of Wes, Sally Sue, and Peggy Sue. These systems can analyze proteins up to 440 kDa in size, either with an antibody-based assay using the standard kits available, or without an antibody using the Total Protein Master Kit.
“For years, researchers have been forced to run gels for either Western blot analysis or total protein detection,” commented John Proctor, Director of Marketing at ProteinSimple. “With this new total protein kit, researchers will never need to run a protein gel again.”
Meet the entire Simple Western family at www.proteinsimple.com.
BEIJING, July 25, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2014, after…
SINGAPORE, July 25, 2014 /PRNewswire/ — The Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP) is, in advance of World Hepatitis Day on 28 July 2014, calling upon governments across Asia-Pacific to develop and implement coordinated national action plans to fight viral hepatitis. Viral hepatitis is a leading cause of liver cancer.
In Asia Pacific, chronic hepatitis B and hepatitis C together with other forms of viral hepatitis kill over one million people per year, a death rate that is three times higher than HIV/AIDS.1
Chronic hepatitis B and hepatitis C are major reasons for liver diseases, causing 78% of all liver cancer globally.2 Across the world in less developed regions, people living with hepatitis B and hepatitis C infections are most susceptible to developing cancer, with data showing that the viruses are responsible for 32% of all new infection-caused cancer cases per year in low- and middle-income countries, more than any other types of infection.3
Data from the 2014 World Cancer Report show that liver cancer is now the second most common cause of cancer death in Asia Pacific.4
Although viral hepatitis is an enormous and complex health threat, practical actions can substantially reduce the disease burden. The World Health Organization (WHO) has developed a four-part blueprint — the Framework for Global Action — that guides national governments on effective ways to prevent and control the spread of viral hepatitis. The Framework has four parts, or Axes, which can be summarized as “ASAP”:
A for Awareness raising, partnership promotion and resource mobilization (Axis 1)
S for Scientific evidence to drive policy and action (Axis 2)
A for Access to immunization and information to prevent transmission (Axis 3)
P for Provision of screening, care and treatment (Axis 4)
This practical framework can be of great assistance to governments across the region, as Professor Ding-Shinn Chen, Chair of CEVHAP and Immediate Past Dean of the College of Medicine, National Taiwan University, explains: “Socio-economic conditions vary between Asia-Pacific countries, but through front-line clinical practice and extensive research across the region, CEVHAP experts have found that the actions recommended by the WHO Framework for Global Action are applicable and urgently needed in most countries. We ask national governments use the framework as a guide to develop national action plans as soon as possible.”
This call to action was recently echoed by the World Health Assembly resolution on viral hepatitis, which urges member states to develop and implement coordinated national action plans for preventing, diagnosing and treating viral hepatitis. The new resolution on viral hepatitis (WHA67.6) was unanimously adopted during the 67th World Health Assembly in May 2014, representing a worldwide consensus on the need for more concrete action to fight viral hepatitis.
According to the WHO’s latest survey of ministries of health worldwide, only half of the countries surveyed in Asia Pacific have a national action plan to prevent and control the spread of viral hepatitis.5 This is despite the fact that 70% of the world’s hepatitis-related deaths occur in the region.1
National governments are not alone in the fight against viral hepatitis. Drawing on lessons learnt from combating HIV/AIDS, tuberculosis and malaria, cross-sector partnerships have proven to be effective in mobilizing the expertise and resources needed to prevent and treat diseases of wide prevalence and high mortality.
Cross-sector partnerships will be particularly critical to the development of a much-needed international funding mechanism. Funding issues present a significant barrier to the ability of governments to implement comprehensive measures aimed at reducing the disease burden of viral hepatitis, especially in low and mid-income countries.
Professor Stephen Locarnini, Director of the WHO Regional Reference Laboratory for Hepatitis B at the Victorian Infectious Diseases Reference Laboratory (VIDRL) and Joint Secretary of CEVHAP, says: “Over the past decade, we have seen the emergence of many avenues of funding which have significantly broadened access to diagnostics and treatments for diseases such as HIV/AIDS, tuberculosis and malaria and we believe the same can be achieved for viral hepatitis. It is time for governments to invest in their people’s health and liver health must be the top priority. WHO has given a Framework to guide the development of national action plans and we urge them to use it.”
Available upon request:
- Fact sheet and info-graphic on Asia Pacific viral hepatitis and liver cancer mortality
- Fact sheet and info-graphic on the WHO Framework for Global Action
The Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP) is the first organization of its kind in the region, established as an independent, multidisciplinary body to advocate for public policy reform to reduce the burden of and ultimately eliminate viral hepatitis in Asia Pacific.
Incorporated in October 2010, CEVHAP membership is comprised of many world-renowned hepatitis experts, including people living with the infections, utilizing the collective expertise of its members to assist the region through partnership with a broad range of stakeholders, including government bodies in public policy formation and health education.
CEVHAP is working closely with the WHO, having assisted the WHO in launching its landmark Global Hepatitis Network in Singapore in June 2013, as well as having taken part in the WHO Global Partners’ Meeting on Hepatitis in March 2014. For more information, please visit www.cevhap.org, or follow CEVHAP on:
World Hepatitis Day 2014 in Asia Pacific
The seventh annual World Hepatitis Day will take place on Monday, 28 July 2014, as part of an on-going campaign launched by the World Hepatitis Alliance in 2008. This is the fourth year that CEVHAP has helped support and coordinate World Hepatitis Day in Asia Pacific and also the fourth year that the WHO has endorsed World Hepatitis Day.
In Asia Pacific, CEVHAP’s members across Asia Pacific will be coordinating a wide range of events and activities to mark World Hepatitis Day.
Global Response to Viral Hepatitis
The first WHO resolution on viral hepatitis was adopted in 2010 (WHA63.18) and has, over the last three years, led to the formation of a dedicated viral hepatitis unit within the WHO, the development of the WHO Framework for Global Action and most recently, the founding of a WHO Global Hepatitis Network, of which CEVHAP is a member. Information regarding the Global Hepatitis Programme, Framework and Network can be found here:
In May 2014, the World Health Assembly adopted the second WHO resolution on viral hepatitis (WHA67.6), providing guidance to governments on how to prioritize actions to tackle all forms of viral hepatitis in a coordinated manner. The resolution requests that the WHO establishes a monitoring system to track progress made by member states, and consider setting goals for the elimination of hepatitis B and C. The resolution also calls, for the first time, upon all UN funds, programs and agencies to move viral hepatitis up their agenda. More information regarding the new resolution can be found here:
1. Institute for Health Metrics and Evaluation, University of Washington. Global Burden of Disease Study 2010. 2013. Available: http://www.healthmetricsandevaluation.org/gbd (data on file).
2. JF Perz1 et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of Hepatology, 45(4):529-38. 2006.
3. de Martel, C et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncology, 13(6):607-6015. 2012.
4. International Agency for Research on Cancer, World Health Organization. GLOBOCAN 2012. 2013. Available: http://globocan.iarc.fr (data on file).
5. World Health Organization. Global policy report on the prevention and control of viral hepatitis in WHO Member States. 2013. Available: http://www.who.int/csr/disease/hepatitis/global_report/en/index.html
For further information please contact:
MELBOURNE, Australia, July 24, 2014 /PRNewswire/ —
Sir Bob Geldof Says the ‘Last Mile’ of the HIV Epidemic Must be Funded
Sir Bob Geldof told delegates at AIDS 2014, the 20th International AIDS Conference, that the “preposterous reluctance” of governments to fund HIV programs in developing countries is “disgraceful”, especially as the journey to the end of the HIV epidemic is “in the last mile”.
The renowned anti-poverty campaigner made the comments at the conference in Melbourne today as he reflected on the impact of HIV on developing nations.
Geldof said that the HIV epidemic in low income countries is “inextricably linked” to poverty, and he strongly criticized wealthy nations for reneging on foreign aid commitments.
The theme of the conference today (Thursday 24 July) was ‘making the long term short term’, and activities began with plenary presentations about fast-tracking the global HIV response.
The escalating HIV epidemic in Eastern Europe and Central Asia was explored in a special session featuring representatives from Russia, Lithuania and Moldova. The panel considered the regions intersecting epidemics of HIV, injecting drug use, hepatitis C and tuberculosis, as well as solutions to issues such as poor access to treatment and the marginalisation and criminalisation of men who have sex with men and people who inject drugs.
Morning’s sessions included a discussion on the worrying trends of HIV transmission and co-infection in prisons; how cultural and political environments are impacting on the health outcomes of indigenous populations throughout the world; and strategies for making workplaces more inclusive and supportive of people with HIV.
Sessions in the afternoon explored a range of subjects such as: the challenges of being transgender in Asia and the Pacific; cultural sensitivity training for sexual health workers in Islamic countries; and how sacred texts can be used to talk effectively about sexuality and diversity.
The Global Village, the conference’s international showcase of community related HIV programmes and activities, welcomed Geldof to the village, and showed him around the wide range of events including theatrical and dance performances, fashion shows, film screenings and music recitals, as well as discussions on a variety of issues.
To read the full text of this press release please visit:
Photo gallery for day 4 can be found at: http://aids2014.smugmug.com/Thursday-24-July-2014
Caption: Sir Bob Geldof with AIDS 2014Local Co-chair Sharon Lewin – promoting the AIDS 2014 Melbourne Declaration – Nobody Left Behind
Photo credit: International AIDS Society/Steve Forrest
2.2 Billion People Are Poor or Near-Poor, Warns 2014 Human Development Report on Vulnerability and Resilience
TOKYO, July 24, 2014 /PRNewswire/ — Persistent vulnerability threatens human development, and unless it is systematically tackled by policies and social norms, progress will be neither equitable nor sustainable. This is the core premise of the 2014 Human Development Report, launched here today by Prime Minister of Japan Shinzo Abe, United Nations Development Programme (UNDP) Administrator Helen Clark and Director of the Human Development Report Office Khalid Malik.
Entitled Sustaining Human Progress: Reducing Vulnerabilities and Building Resilience, the Report provides a fresh perspective on vulnerability and proposes ways to strengthen resilience.
According to income-based measures of poverty, 1.2 billion people live with $1.25 or less a day. However, the latest estimates of the UNDP Multidimensional Poverty Index reveal that almost 1.5 billion people in 91 developing countries are living in poverty with overlapping deprivations in health, education and living standards. And although poverty is declining overall, almost 800 million people are at risk of falling back into poverty if setbacks occur.
“By addressing vulnerabilities, all people may share in development progress, and human development will become increasingly equitable and sustainable,” stated UNDP Administrator Helen Clark today.
The 2014 Human Development Report comes at a critical time, as attention turns to the creation of a new development agenda following the 2015 deadline for achieving the Millennium Development Goals.
Zeroing in on what holds back progress
The Report holds that as crises spread ever faster and further, it is critical to understand vulnerability in order to secure gains and sustain progress.
It points to a slowdown in human development growth across all regions, as measured by the Human Development Index (HDI). It notes that threats such as financial crises, fluctuations in food prices, natural disasters and violent conflict significantly impede progress.
“Reducing both poverty and people’s vulnerability to falling into poverty must be a central objective of the post-2015 agenda,” the Report states. “Eliminating extreme poverty is not just about ‘getting to zero;‘ it is also about staying there.”
A human development lens on who is vulnerable and why
“Reducing vulnerability is a key ingredient in any agenda for improving human development,” writes Nobel laureate Joseph Stiglitz, in a contribution to the Report. “[We] need to approach it from a broad systemic perspective.”
The 2014 Report takes such an approach, using a human development lens to take a fresh look at vulnerability as an overlapping and mutually reinforcing set of risks.
It explores structural vulnerabilities – those that have persisted and compounded over time as a result of discrimination and institutional failings, hurting groups such as the poor, women, migrants, people living with disabilities, indigenous groups and older people. For instance, 80 percent of the world’s elderly lack social protection, with large numbers of older people also poor and disabled.
The Report also introduces the idea of life cycle vulnerabilities, the sensitive points in life where shocks can have greater impact. They include the first 1,000 days of life, and the transitions from school to work, and from work to retirement.
“Capabilities accumulate over an individual’s lifetime and have to be nurtured and maintained; otherwise they can stagnate and even decline,” it warns. “Life capabilities are affected by investments made in preceding stages of life, and there can be long-term consequences of exposure to short-term shocks.”
For example, in one study cited by the Report, poor children in Ecuador were shown to be already at a vocabulary disadvantage by the age of six.
Timely interventions – such as investments in early childhood development – are therefore critical, the Report states.
Poor countries can afford universal provision of basic social services
The Report advocates for the universal provision of basic social services to enhance resilience, refuting the notion that only wealthy countries can afford to do this. It presents a comparative analysis of countries of differing income levels and systems of government that have either started to implement or have fully implemented such policies.
Those countries include not only the usual suspects such as Denmark, Norway and Sweden, but also fast-growing economies such as Republic of Korea and developing countries such as Costa Rica.
“These countries started putting in place measures of social insurance when their Gross Domestic Product (GDP) per capita was lower than India’s and Pakistan’s now,” the Report observes.
However, “there may be instances in which equal opportunities require unequal treatment,” notes Khalid Malik, Director of UNDP’s Human Development Report Office. “Greater resources and services may need to be provided to the poor, the excluded and the marginalized to enhance everyone’s capabilities and life choices.”
Putting full employment back atop the global policy agenda
The Report calls for governments to recommit to the objective of full employment, a mainstay of macroeconomic policies of the 1950s and 1960s that was overtaken by competing policy goals following the oil shocks of the 1970s.
It argues that full employment yields social dividends that surpass private benefits, such as fostering social stability and cohesion.
Acknowledging the challenges that developing countries face with respect to full employment, it urges a focus on structural transformation “so that modern formal employment gradually incorporates most of the workforce,” including a transition from agriculture into industry and services, with supporting investments in infrastructure and education.
Social protection is feasible at early stages of development
The majority of the world’s population lacks comprehensive social protections such as pensions and unemployment insurance. The Report argues that such measures are achievable by countries at all stages of development.
“Providing basic social security benefits to the world’s poor would cost less than 2 percent of global GDP,” it asserts. It cites estimates of the cost of providing a basic social protection floor – including universal basic old age and disability pensions, basic childcare benefits, universal access to essential health care, social assistance and a 100-day employment scheme – for 12 low-income African and Asian countries, ranging from about 10 percent of GDP in Burkina Faso to less than 4 percent of GDP in India.
“A basic social protection package is affordable so long as low-income countries reallocate funds and raise domestic resources, coupled with support by the international donor community,” it states.
Collective effort, coordinated action needed at global level
The Report also calls for stronger collective action, as well as better global coordination and commitment to shoring up resilience, in response to vulnerabilities that are increasingly global in origin and impact.
Threats ranging from financial crises to climate change to conflicts are trans-national in nature, but the effects are experienced locally and nationally and often overlap. Take the case of Niger, which has faced severe food and nutrition crises brought on by a series of droughts. At the same time, Niger had to cope with an influx of refugees fleeing conflict in neighbouring Mali.
Trans-national threats cannot be resolved by individual nations acting independently; they require a new focus from the international community that goes beyond short-term responses like humanitarian assistance, the Report argues.
To increase support for national programmes and open up policy space for nations to adapt universalism to specific country conditions, the Report calls for “an international consensus on universal social protection” to be included in the post-2015 agenda.
Time Is Now To Introduce Universal Social Services and Protection in Asia and the Pacific, Says 2014 Human Development Report on Vulnerability and Resilience
TOKYO, July 24, 2014 /PRNewswire/ — Staggering rates of poverty, high inequality and frequent natural disasters and crises threaten the progress of human development in Asia and the Pacific. Addressing these challenges requires a host of initiatives, including universal provision of social services and a strong system of social security benefits, says the 2014 Human Development Report, released in Tokyo today by the United Nations Development Programme (UNDP).
The Report, entitled Sustaining Human Progress: Reducing Vulnerabilities and Building Resilience, offers a fresh perspective on what makes people vulnerable, and proposes ways to strengthen resilience.
Across Asia and the Pacific, over a billion people live just above the extreme poverty line, on more than US$1.25 but less than US$2.50 a day. The report asserts that those who face multiple deprivations are especially at risk of falling back into poverty if a disaster or crisis should occur.
The Report introduces the idea of life cycle vulnerabilities, which arise from sensitive points in life where shocks can have greater impact. It stresses the importance of the first 1,000 days of life, and of the transitions from school to work, and from work to retirement.
The Report urges governments to commit to the universal provision of basic social services and social protection to build resilience, especially for the poor and other vulnerable groups. It argues that countries in Asia and the Pacific do not have to wait to become rich in order to provide adequate social protection or basic social services. It shows that Nordic countries, as well as countries such as Republic of Korea and Costa Rica, were able to provide universal basic social services when their per capita GDP was lower than that of India or Pakistan today.
Making the case that cohesive societies work better, the Report calls for strong social protections such as pensions and unemployment insurance for countries at all stages of development.
The Report also highlights that a lack of decent, well paid jobs – especially for youth – is a major challenge in Asia and the Pacific. In many countries of the region, youth unemployment is relatively high: 23 percent in Iran, 22 percent in Indonesia, 17 percent in Sri Lanka, 16 percent in Philippines and Samoa and 14 percent in Timor-Leste. The Report urges governments to fast-track education reform policies and to accelerate broad-based economic growth to create decent and well paid jobs that are essential to improving living standards.
In addition, food insecurity, violence against women, and civil conflict and disaster risks (such as landslides and rising sea levels) linked to climate change further threaten the security of millions of people.
“By addressing vulnerabilities, all people may share in development progress, and human development will become increasingly equitable and sustainable,” UNDP Administrator Helen Clark said today.
Below are additional regional highlights of the Report.
- There is no country in the very high human development group from the region.
- The average HDI value for the region, at 0.588, is below the world average of 0.702.
East Asia and the Pacific
- There are six countries in the high human development group from the region, 11 in the medium and three in the low human development group.
- The average HDI value for the region is 0.703, slightly above the world average of 0.702.
Additional information on the 2014 Human Development Report is available here.
For information about the Human Development Index, http://hdr.undp.org/en/2014-report
MOUNTAIN VIEW, Calif., July 23, 2014 /PRNewswire/ —
10:00 a.m. EDT on Thursday, July 31, 2014
Online, with free registration
Frost & Sullivan Technical Insights
Research Analyst Bhargav Rajan
Given increasing healthcare consumerism and demand for round-the-clock healthcare delivery, hospitals and providers must upgrade their healthcare IT infrastructure to accommodate patient and provider needs. This briefing will investigate the changing technology landscape in hospitals globally and will specifically focus on how hospitals in North America and Europe are adopting health information systems (HIS).
Attend this webinar to discover:
- Information technology systems in hospitals
- Drivers and restraints of HIS
- A technology and adoption roadmap of HIS
As this presentation will discuss emerging trends and opportunities for the information technology providers globally, it will benefit hospitals, healthcare providers, insurance companies and payers, IT and Information Technology Enabled Service (ITES) players, telecom providers as well as applications developers and Software as a Service (SaaS) providers.
“The need for greater efficiency in healthcare delivery and the emergence of integrated healthcare systems offer tremendous collaboration opportunities between healthcare and information communication technology industries,” said Frost & Sullivan Technical Insights Research Analyst Bhargav Rajan.
“Healthcare delivery in the U.S. is in the midst of a huge upheaval, brought about by legislative and regulatory changes. While some of these changes greatly benefit the adoption of IT platforms in hospitals, other changes mandate greater regulatory compliance and usage guidelines. As with any other market, there are conflicting industry and market forces at play that will keep HIS adoption from being fully realized in the short term.”
- To attend the briefing, email [email protected] your full name, job title, company name, company telephone number, company email address and website, city, state and country.
- Receive a recorded version of the briefing anytime by submitting the aforementioned contact details.
- For more information about Frost & Sullivan’s Healthcare or Technical Insights practice, please visit: http://www.frost.com.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.
Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Frost & Sullivan